A Safety and Efficacy Study of Travoprost 0.004% Compared to Latanoprost 0.005% in Patients With Chronic Angle-Closure Glaucoma

Clinical trial NCT00051181 · COMPLETED

Trial details

NCT number: NCT00051181
Sponsor: Alcon Research
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Glaucoma, Angle-Closure Ocular Hypertension

Start date: 2000-01-01
Primary completion: 2003-06-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.